Page last updated: 2024-08-26

2,2',4,4'-tetrabromodiphenyl ether and Cancer of Ovary

2,2',4,4'-tetrabromodiphenyl ether has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gregoraszczuk, EŁ; Karpeta, A; Maniecka, A1

Other Studies

1 other study(ies) available for 2,2',4,4'-tetrabromodiphenyl ether and Cancer of Ovary

ArticleYear
Different mechanisms of action of 2, 2', 4, 4'-tetrabromodiphenyl ether (BDE-47) and its metabolites (5-OH-BDE-47 and 6-OH-BDE-47) on cell proliferation in OVCAR-3 ovarian cancer cells and MCF-7 breast cancer cells.
    Journal of applied toxicology : JAT, 2016, Volume: 36, Issue:12

    Topics: Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Genes, cdc; Halogenated Diphenyl Ethers; Humans; MAP Kinase Signaling System; MCF-7 Cells; Ovarian Neoplasms; Phosphorylation; Polybrominated Biphenyls; Protein Kinase C-alpha

2016